Atlas Trials

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

Clinical trial NCT04827537 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04827537
Sponsor
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Giardia Lamblia Infection
Start date
2021-01-01
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.